ABSTRACT
INTRODUCTION
Fetal growth disorders are associated with an increased risk of adverse perinatal outcome (APO) [1] [2] [3] [4] and long-term effects 5, 6 . At present, the best clinical surrogate of an intrauterine growth abnormality is the prenatal recognition of small size, defined as small-for-gestational age (SGA), which can be diagnosed by different approaches, including maternal abdominal palpation and/or fundal-height measurement, risk-based selective ultrasound assessment and routine third-trimester ultrasound examination. However, strategies for identifying fetal growth disorders, and consequently minimizing rates of APO and stillbirth, still fail to detect more than 25% of cases [7] [8] [9] [10] . A possible explanation for the failure to identify SGA is the current timing of the third-trimester scan, where applicable, as it is often done early in the third trimester. Current evidence suggests that it should be postponed to later in pregnancy 10, 11 .
A growing body of evidence has found that APO may occur more frequently in fetuses at the end of the spectrum of normality owing to a pathological placental scenario, as demonstrated by histological placental abnormalities, reflecting defective trophoblast invasion in early pregnancy, and lesions compatible with underperfusion 2, 12, 13 . These histological disruptions are reflected as changes in fetoplacental Doppler parameters 13 . Increased resistance in the uterine arteries (UtA) is associated with a higher risk of intrapartum fetal distress, emergency Cesarean section (CS) and admission to the neonatal intensive care unit (NICU) 14, 15 . Fetal middle cerebral artery (MCA) resistance, alone or in combination with umbilical artery (UA) resistance as the cerebroplacental ratio (CPR) [16] [17] [18] [19] [20] [21] , is more reflective of fetal hypoxia and acidemia, and therefore better associated with perinatal outcome and neonatal and infant neurobehavior [22] [23] [24] . We and others have demonstrated previously that umbilical vein blood flow (UVBF), which serves as a more direct indicator of the amount of oxygen and nutrients that are reaching the fetus, can also aid in the prediction of both SGA and APO 13, 25, 26 . Considering this evidence and the timing of the third-trimester scan, it seems reasonable to speculate that combining Doppler measurements with estimated fetal weight (EFW) could improve the antenatal identification of pregnancies at increased risk of fetal growth disorders and APO.
This study was designed to assess the performance of screening for SGA, fetal growth restriction (FGR) and APO by fetal biometry and fetoplacental Doppler evaluation at the routine third-trimester ultrasound examination at 37 weeks' gestation.
METHODS

Study population
Between October 2014 and June 2015, consecutive women with a low-risk singleton pregnancy were prospectively recruited. Each woman attended the Department of Maternal-Fetal Medicine in the Hospital Clinic of Barcelona for a third-trimester ultrasound examination at 37 ± 1 weeks, which included fetal biometry and fetoplacental Doppler assessment. Gestational age was calculated from crown-rump length on first-trimester ultrasound 27 . Pregnancies with early-onset growth impairment (EFW < 10 th centile at 30-34 weeks according to local standards 28 ), structural and/or chromosomal anomalies or evidence of fetal infection were excluded. The local ethics committee approved the study (IRB 2014/760) and each patient gave their written informed consent.
Baseline characteristics
At study inclusion, data on maternal characteristics, including age, ethnicity, low socioeconomic status (routine occupation, long-term unemployment or never worked), body mass index at booking and at 37 weeks, nulliparity (no prior delivery after 22 weeks' gestation), smoking status, method of conception (spontaneous or assisted reproductive technique including ovulation induction, in-vitro fertilization or oocyte donation), medical history (known chronic disease, such as hypertension, diabetes mellitus, autoimmune disorder and congenital or acquired thrombophilic conditions) and obstetric history (including prior pregnancy complicated by stillbirth, FGR or pre-eclampsia) were recorded. Additionally, all data pertaining to follow-up, development of complications, ultrasound evaluations and perinatal outcomes were collected prospectively.
Ultrasound scan and Doppler evaluation
At 37 ± 1 weeks, an ultrasound examination, including fetal biometry and Doppler evaluation, was performed by one experienced operator (S.T.) using a GE Voluson E8 (GE Medical Systems, Zipf, Austria) ultrasound machine equipped with a 6-2-MHz linear curved-array transducer. The following biometric measurements were obtained, adhering to standardized recommendations 29 : biparietal diameter, head circumference, abdominal circumference and femur length. EFW was calculated using Hadlock's formula 30 and the centile was derived from local reference curves 28 . Doppler examination was performed in the absence of fetal movements and voluntarily suspended maternal breathing [31] [32] [33] [34] [35] . Spectral Doppler parameters were obtained automatically from three or more consecutive waveforms, with the angle of insonation as close to 0
• as possible. The UA pulsatility index (UA-PI) was measured in a free-floating cord loop. For UtA Doppler evaluation, the probe was placed on the lower quadrants of the abdomen, angled medially, and color Doppler imaging was used to identify the UtA at the apparent crossover with the external iliac artery. The mean UtA-PI was calculated as the average PI between right and left arteries. Fetal MCA-PI was measured in a transverse view of the fetal head, at the level of its origin from the circle of Willis, and CPR was calculated as the ratio of MCA-PI to UA-PI. The umbilical vein (UV) was sampled from a free-floating cord loop in a longitudinal plane parallel to the transducer and magnified to occupy more than 30% of the image. The internal diameter was measured at three different sites and the mean value of the three measurements was calculated. The time-averaged maximum velocity (TAMXV) was measured in the same portion of the free-floating loop, after adjusting the scanning insonation angle as close to 0
• as possible and always below 30
• ;
angle correction was performed when an insonation angle of 0
• was not possible. Measurements were performed during fetal quiescence from a 10-s steady-state velocity profile. UVBF (mL/min) was calculated as reported previously 34 : UV area (cm 2 ) × 60 × TAMXV (cm/s) × 0.5. Normalized UVBF was calculated as the ratio of UVBF per kg of EFW. A high-pass filter was set at 50 Hz, and energy output levels were lower than 50 mW/cm 2 . All Doppler parameters were transformed to Z-values for gestational age.
Clinical management
All deliveries were attended by a staff obstetrician who was blinded to the results of the Doppler parameters evaluated. Indication for CS for non-reassuring fetal status (NRFS) was based on abnormal fetal heart rate and abnormal fetal scalp blood pH during intrapartum monitoring. Continuous fetal heart monitoring was carried out and tracings were classified according to the following three-tier system 36 : (1) normal: baseline 110-160 beats per min (bpm), variability > 5 bpm and absence of decelerations; (2) suspicious (one non-reassuring criterion present): baseline 100-109 or 161-180 bpm, variability < 5 bpm for less than 90 min, recurrent (>50% contractions) typical variable decelerations for more than 90 min and a single prolonged deceleration for up to 3 min; (3) pathological: more than one non-reassuring criterion or presence of any abnormal feature, including baseline < 100 or > 180 bpm or sinusoidal patterns (more than 10 min), variability < 5 bpm for more than 90 min, recurrent atypical variable decelerations for more than 30 min, late decelerations for more than 30 min and a single prolonged deceleration for more than 3 min.
In cases with a pathological fetal heart rate or a suspicious pattern not presenting as acceleration after digital fetal scalp stimulation 37 , fetal scalp blood sampling was performed and considered abnormal if pH values were < 7.15 or 7.20, respectively, on first and second measurements 30 min apart. If cervical conditions did not allow fetal scalp sampling, CS was considered for NRFS based on the persistence of an abnormal tracing after pessary withdrawal, oxytocin suspension and 10 min of intravenous infusion of 200 μg/min ritrodine.
All cases with adverse outcome were assessed formally to ensure that the management protocol had been followed correctly.
Outcome definitions
SGA was defined as a birth weight between the 3 rd and 10 th centiles, and FGR was defined as a birth weight < 3 rd centile, by customized local standards 28 . Pre-eclampsia was defined according to the criteria of the International Society for the Study of Hypertension in Pregnancy 38 . APO was defined as the presence of NRFS requiring emergency CS, a 5-min Apgar score of < 7 or neonatal metabolic acidosis at birth, defined as UA pH ≤ 7.15 and base excess > 12 mEq/L 39 . All cases with adverse outcome were evaluated systematically to assure adherence to such guidelines.
Statistical analysis
Normal distributions were assured by the Shapiro-Wilk test. One-way analysis of variance (ANOVA) with post-hoc Bonferroni correction for multiple comparisons and Pearson's chi-square test were used to test the hypothesis of linear trend across the study groups (appropriate-for-gestational age (AGA), SGA, FGR) of quantitative and qualitative variables, respectively.
Odds ratios and their 95% CI were calculated by logistic regression analysis. Predictive models for SGA, FGR and APO were also constructed by logistic regression analysis, for which selection of variables was performed by backwards stepwise procedure, in order to add back potential variables if they later appeared to be significant. In agreement with the process for significant variables to be re-introduced into the model, two separate significance levels were chosen (P = 0.05 for those included and P = 0.1 for those left out).
The predictive performance for SGA, FGR and APO was determined by receiver-operating characteristics (ROC) curve analysis. Paired ROC curves were compared by the DeLong method 40 and P < 0.05 was considered to be statistically significant.
IBM SPSS 23.0 (Armonk, NY, USA) and R version 2.15.1 (The R Foundation for Statistical Computing) with the package pROC version 1.7.2 software were used for statistical analysis and graph construction.
RESULTS
A total of 1000 women fulfilling the inclusion criteria were considered for the study. Of these, 54 were excluded for the following reasons: congenital malformation (n = 8), lost to follow-up (n = 36) or had missing data (n = 10), leaving 946 pregnancies for analysis. Among these, 817 (86.4%) were categorized as AGA, 89 (9.4%) as SGA and 40 (4.2%) as FGR. Baseline demographic characteristics of the study groups are summarized in Table 1 . Maternal characteristics were similar across all groups, with significant trends for ethnicity (Black and Asian) and smoking status.
A summary of the ultrasound and Doppler parameters in each group is given in Table 2 and obstetric and perinatal outcomes are given in Table 3 . As expected, the proportion of abnormal Doppler parameters increased with the severity of the growth restriction, as did the proportion of APO (P = 0.001). Table 4 shows the association of each individual parameter with SGA, FGR and APO. EFW and most Doppler parameters at 37 weeks were significantly associated with SGA and FGR, however, only CPR and UVBF corrected for EFW were associated with APO. Table 5 and Figures 1-3 show the predictive performance of EFW centile, Doppler parameters and their combination for the prediction of SGA, FGR and APO. For SGA, both CPR and UtA Doppler were independently and significantly associated, however, they did not significantly improve the predictive capacity provided by EFW centile alone. For FGR, only CPR was independently and significantly associated, however, this parameter did not significantly improve the prediction provided by EFW centile alone. For APO, both CPR and UVBF were significantly and independently associated, and their combination with EFW centile improved the predictive capacity provided by EFW centile alone (area under the ROC curve, 0.54 vs 0.67; P = 0.011). At a fixed 10% false-positive rate (FPR), the detection rate for APO Data are given as mean ± SD or n (%). *Routine occupation, long-term unemployment or never worked. †Groups compared using one-way ANOVA (post-hoc Bonferroni correction), with linear polynomial contrast or linear-by-linear association test, as appropriate, with P < 0.05 considered statistically significant: ‡AGA vs SGA; §AGA vs FGR; ¶SGA vs FGR. BMI, body mass index; PE, pre-eclampsia. 
DISCUSSION
This study assessed the performance of the antenatal identification of SGA, FGR and APO using a set of Doppler parameters, considered as markers for impaired placentation in late-onset growth disorders, at 37 weeks' gestation. While little is gained from Doppler evaluation in the prediction of SGA or FGR when standard fetal biometry is measured, the performance of Doppler outdoes that of fetal biometry alone for the prediction of APO, albeit with a low predictive capacity. Antenatal detection of FGR has the potential to improve a number of perinatal outcomes 5, 6, 41 . However, it would be biologically implausible that all cases of FGR occur in small babies. In fact, between the 10 th Table 3 Obstetric and perinatal outcomes of 946 women with low-risk singleton pregnancy with fetoplacental Doppler assessment at 37 weeks' gestation, stratified according to birth weight into appropriate-for-gestational age (AGA), small-for-gestational age (SGA) and fetal growth restricted (FGR) and 50 th centiles for birth weight, perinatal mortality is increased 42 , suggesting that a proportion of cases with placental insufficiency exhibit growth within normal ranges. This raises the question of whether fetal and maternal Doppler parameters could identify this latent placental insufficiency even when fetal growth is normal.
UtA Doppler evaluation provides a non-invasive approach for the recognition of defective trophoblastic Combined Doppler models included: *cerebroplacental ratio (CPR) and uterine artery pulsatility index (UtA-PI); †CPR and umbilical vein blood flow (UVBF) corrected by estimated fetal weight (EFW). AUC, area under receiver-operating characteristics curve; DR, detection rate; FPR, false-positive rate.
invasion in early pregnancy or for detecting fetal underperfusion lesions in the second half of pregnancy 12, 14, 43 . In a previous study, we verified the potential advantage of UtA Doppler at the time of the routine third-trimester ultrasound scan for its capacity to detect SGA neonates with different pathophysiological pathways, and reported a trend towards a significant association between abnormal UtA Doppler and the subsequent development of SGA 44 . Fadigas et al. 11 found increased UtA-PI at 35-37 weeks in women who delivered an SGA neonate in the absence of pre-eclampsia, however, it did not improve the predictive performance for SGA achieved by combined testing with maternal characteristics and fetal biometry alone. Similar findings were reported for the prediction of APO by Valiño et al. 45 . Our results are in line with the findings of both these studies.
In recent decades, many studies have acknowledged that, in cases of SGA, low CPR or low MCA-PI is associated with an increased risk of fetal hypoxemia and/or acidemia, APO and long-term neurodevelopmental damage 18, 20, 46, 47 . In our study, the role played by CPR is different according to the outcome evaluated. For SGA (and FGR), CPR gave minimal predictive improvement to that provided by standard fetal biometry at 37 weeks. This is not surprising and can be explained by the definition used for the growth disorder, based on customized birth weight, which is not always able to discriminate between constitutionally small neonates and those that are growth restricted owing to impaired placentation and are at increased risk of short-and long-term effects. On the other hand, when focusing our attention on the consequences of placental insufficiency, defined as APO, fetal biometry performs poorly, while, as expected, CPR improves the prediction by almost two-fold when combined with EFW. This is in keeping with the results of a previous study by Prior et al. 48 , who demonstrated that, independently of fetal size, CPR measured within 72 h of delivery could identify those likely to require obstetric intervention for intrapartum fetal compromise. Similarly, several other retrospective studies examined mixed-risk pregnancies at ≥ 37 weeks' gestation, reporting that low CPR, measured within 2 weeks of delivery, was associated with the need for operative delivery for presumed fetal compromise, low neonatal blood pH and NICU admission, irrespective of fetal size [49] [50] [51] . Despite the evidence for such an association, its predictive ability for APO is still poor. The present study shows that, even with a FPR of 20%, we still fail to identify prenatally the majority of cases that will have APO. Akolekar et al. 52 evaluated CPR at 35-37 weeks' gestation in 6178 women as part of routine screening for APO, irrespective of fetal size or the interval from assessment to delivery, concluding that the performance of low CPR in screening for each adverse outcome is poor, with detection rates of 6-15% and a FPR of about 6%. From this cumulative evidence, we speculate that perinatal outcome is influenced not only by antepartum factors, but also by many intrapartum confounders, independent of the efficiency of the hemodynamic model, suggesting that the current definition of APO, at least as it is traditionally defined, is inadequate 50, 51, 53 .
UVBF is considered a more direct and physiological measurement of vascular placental function than are UA Doppler indices and is considered a surrogate parameter for determining the quantity of oxygen and nutrients that reach the fetus 54, 55 . In a previous study, we demonstrated that the addition of UVBF to fetal MCA-PI improved the prediction of emergency CS for NRFS and neonatal metabolic acidosis in a population of late-onset SGA fetuses. These findings suggest the use of a combination of these two Doppler parameters for establishing a subgroup of late-onset SGA fetuses at increased risk of APO 12 . Additionally, we have found previously that, in late-onset SGA, UtA-PI and UVBF can be used as markers for placental underperfusion, reflecting the degree of placental damage, which is not detected by UA Doppler 13 . Our current study extends these findings to the whole spectrum of fetal size, showing that these Doppler parameters are associated not only with SGA, but also with APO. This was not unexpected since, near term, there is a reduction in the oxygen transport capacity per unit of fetal weight, which may account for the higher risk of intrapartum fetal distress and neonatal metabolic acidosis in term SGA fetuses and contribute to an adverse intrauterine environment in post-term pregnancies 56 . Consequently, UVBF Doppler assessment could enable the identification of patients at high risk for emergency CS for NRFS and allow for better personalized patient counseling and the more efficient use of resources in cases of suspected FGR.
This study has several strengths. First, we evaluated, at 37 weeks' gestation, the performance of a set of Doppler parameters qualified as markers for placental insufficiency in late-onset SGA, and compared them with EFW for the prediction of SGA, FGR and APO. Second, we recruited a prospective cohort of pregnant women attending routine assessment for FGR, booked at a specified gestational age (37 weeks) at the end of the third trimester. Third, the obstetricians in charge of labor monitoring were blinded to the Doppler results.
We also acknowledge some limitations to our study. We used an APO composite, selecting only four of a wide range of well-accepted indicators for APO. Additionally, data on histological evaluation of the placenta are lacking, which would have been useful to understand better the role played by each Doppler parameter.
In conclusion, in low-risk pregnancies, Doppler evaluation at 37 weeks' gestation does not improve the prediction of SGA and FGR achieved by EFW alone, but when combined with EFW it can improve the prediction of APO, although not markedly. As a consequence, further investigation is required to assess additional parameters at the end of the third trimester that are able to increase the predictive capacity for APO.
